Outcome Of Dose-Adjusted Decitabine Regimen Compared With FLAG Regimen In The Treatment Of Relapsed/Refractory Acute Myeloid Leukemia

被引：1
|
作者：
Wu, Qian
He, Guangsheng
Wu Depei
Sun, Aining
Qiu, Huiying
Jin, Zhengming
Miao, Miao
Tang, XiaoWen
Han, Yue
Shen, Yiming
Chen, Feng
Hu, Xiaohui
Jin, Song
Zhang, Xuhui
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.5031.5031
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5031
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Efficacy and Safety of Decitabine Combined with IA Regimen in the Treatment of Newly Diagnosed Acute Myeloid Leukemia
    Kuang, Lifen
    Li, Juan
    BLOOD, 2021, 138
  • [42] Venetoclax in combination with azacitidine or decitabine in relapsed/refractory acute myeloid leukemia
    Che, Yue
    Tan, Wanqing
    Liu, Ying
    Liu, Haitao
    Li, Lanlan
    Qin, Fangmei
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2024, 23 (01) : 209 - 214
  • [43] Effect of modified FLAG regimen therapy on 33 patients with relapsed/refractory leukemia.
    Meng, FY
    Yang, LJ
    Xu, B
    Liu, XL
    Zheng, WY
    Zhang, Y
    Fen, H
    Xu, D
    Sun, J
    Liu, QF
    BLOOD, 2003, 102 (11) : 244B - 244B
  • [44] The Clinical Outcome of FLAG Chemotherapy without Idarubicin in Patients with Relapsed or Refractory Acute Myeloid Leukemia
    Lee, Se Ryeon
    Yang, Deck Hwan
    Ahn, Jae Sook
    Kim, Yeo Kyeoung
    Lee, Je Jung
    Choi, Young Jin
    Shin, Ho Jin
    Chung, Joo Seop
    Cho, Yoon Young
    Chae, Yee Soo
    Kim, Jong Gwang
    Sohn, Sang Kyun
    Kim, Hyeoung Joon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2009, 24 (03) : 498 - 503
  • [45] A novel intensive conditioning regimen for allogeneic hematopoietic stem cell transplantation in the treatment of relapsed/refractory acute myeloid leukemia
    Sun, Yanling
    Zhang, Jingwen
    Long, Bing
    Zhang, Xiangzhong
    Wen, Ruijuan
    He, Yi
    LI, Xudong
    NEOPLASMA, 2021, 68 (06) : 1351 - 1358
  • [46] Decitabine as epigenetic priming with CLAG induce improved outcome of relapsed or refractory acute myeloid leukemia in children
    Zhang, Na
    Li, Hong
    Wang, Dan
    Wang, Zhen
    Zhu, Jia-Shi
    Chen, Kai
    Jiang, Hui
    Shao, Jing-Bo
    Cai, Cheng
    CLINICAL EPIGENETICS, 2024, 16 (01)
  • [47] Treatment for Relapsed/Refractory Acute Myeloid Leukemia
    Thol, Felicitas
    Heuser, Michael
    HEMASPHERE, 2021, 5 (06): : E572
  • [48] Treatment of Relapsed/Refractory Acute Myeloid Leukemia
    Bose, Prithviraj
    Vachhani, Pankit
    Cortes, Jorge E.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (03)
  • [49] Treatment of Relapsed/Refractory Acute Myeloid Leukemia
    Prithviraj Bose
    Pankit Vachhani
    Jorge E. Cortes
    Current Treatment Options in Oncology, 2017, 18
  • [50] Outcome of Refractory and Relapsed Patients with Acute Myeloid Leukemia
    Niederwieser, Dietger
    Krahl, Rainer
    Kahle, Christoph
    Scholl, Sebastian
    Wolf, Hans-Heinrich
    Cross, Michael
    Hegenbart, Ute
    Peter, Norma
    Niederwieser, Christian
    Florschuetz, Axel
    Reifenrath, Kolja F. B.
    Zojer, Niklas
    Junghanss, Christian
    Sayer, Herbert
    Schmidt, Volker
    Maschmeyer, Georg
    Hochhaus, Andreas
    Fischer, Thomas
    Al-Ali, Haifa Kathrin
    Heinicke, Thomas
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 106 - 106
12345